Have any questions?
Menu
Zarqa’s screening offers an extensive screening panel covering over 300 common autosomal recessive and X-linked disorders. It empowers individuals and families to make informed decisions regarding pregnancy and family planning by providing comprehensive genetic insights.
No. of Genes: 330
Turnaround Time (TAT): 25 Business Days
Coverage: ≥99.00% ≥20x
Techniques: NGS including CNV Analysis, Sanger Sequencing (CYP21A2), Repeat Expansion Analysis (FMR1), MLPA (SMN1)
Details: Complete panel evaluation with CNV analysis of 34 genes
No. of Genes: 330 (for each partner)
Turnaround Time (TAT): 30 Business Days
Coverage: ≥99.00% ≥20x
Techniques: NGS including CNV Analysis, MLPA (SMN1), Sanger Sequencing (CYP21A2), Repeat Expansion Analysis (FMR1)
Details: Complete panel evaluation with CNV analysis of 34 genes for each partner
Zarqa’s screening covers a wide range of autosomal recessive and X-linked disorders, providing a thorough evaluation.
By offering insights into potential genetic risks, Zarqa’s screening enables individuals and couples to make informed decisions regarding family planning.
Utilizing cutting-edge techniques such as NGS, CNV analysis, Sanger sequencing, and MLPA ensures high-quality and reliable results.
Zarqa’s screening Duo allows for tailored screening for both partners, enhancing the understanding of genetic risks within the family.
Trust in Comprehensive Genetic Screening
Zarqa’s screening offers peace of mind through comprehensive genetic screening, providing individuals and families with the knowledge to make informed decisions about their reproductive health.
Get The Latest Updates via email. Any time you may unsubscribe
Copyright © 2024 Zarqa Genomics Lab, All rights reserved